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hrombospondin (TSP) signals focal adhesion disassem-
bly (the intermediate adhesive state) through interactions
with cell surface calreticulin (CRT). TSP or a peptide
(hep I) of the active site induces focal adhesion disassembly
through binding to CRT, which activates phosphoinositide
3-kinase (PI3K) and extracellular signal–related kinase
 
(ERK) through G
 
 
 
i2
 
 proteins. Because CRT is not a trans-
membrane protein, it is likely that CRT signals as part of a
coreceptor complex. We now show that low density lipo-
protein receptor–related protein (LRP) mediates focal adhesion
disassembly initiated by TSP binding to CRT. LRP antagonists
(antibodies, receptor-associated protein) block hep I/TSP-
T
 
induced focal adhesion disassembly. LRP is necessary for
TSP/hep I signaling because TSP/hep I is unable to stimulate
focal adhesion disassembly or ERK or PI3K signaling in
ﬁbroblasts deﬁcient in LRP. LRP is important in TSP–CRT
signaling, as shown by the ability of hep I to stimulate asso-
ciation of G
 
 
 
i2
 
 with LRP. The isolated proteins LRP and CRT
interact, and LRP and CRT are associated with hep I in
molecular complexes extracted from cells. These data
establish a mechanism of cell surface CRT signaling through
its coreceptor, LRP, and suggest a novel function for LRP in
regulating cell adhesion.
 
Introduction
 
Interactions of cells with the ECM modulate most cellular
functions. Focal adhesions are specialized submembranous
assemblies of both structural and signaling molecules that
link the actin cytoskeleton to receptors such as integrins and
syndecan-4, which recognize ECM molecules (Burridge and
Chrzanowska-Wodnicka, 1996). Focal adhesions transmit
both mechanical and biochemical signals that regulate cell
shape and cytoskeletal organization, cell motility, cell cycle
progression, gene expression, and cell survival (Yamada and
Geiger, 1997; Horwitz and Werb, 1998).
Thrombospondins (TSPs)* 1 and 2, tenascin-C, and
SPARC are matricellular proteins, which when presented to
cells as soluble proteins, stimulate a transition in cell adhesion
from a state of strong adhesion to one of intermediate adhesion.
This is characterized by a restructuring of focal adhesion
plaques with dispersal of vinculin and 
 
 
 
-actinin and reorgani-
zation of actin stress fibers while maintaining integrin clusters
and a spread cell shape (Murphy-Ullrich, 2001). The inter-
mediate adhesive state is regarded as the phenotype of an
adaptive response that facilitates motility and potentially
induces cell survival signals (Murphy-Ullrich, 2001).
TSP signals focal adhesion disassembly through interactions
of a 19 amino acid sequence from its NH
 
2
 
-terminal heparin-
binding domain with a cell surface form of calreticulin
(CRT; Goicoechea et al., 2000, 2002). TSP–CRT signaling
of focal adhesion disassembly is pertussis toxin (PTX)–sensitive
and involves both G
 
 
 
i2
 
 and G
 
  
 
 subunits (Orr et al., 2002).
TSP/hep I binding to CRT stimulates a PTX-dependent
activation of phosphoinositide 3-kinase (PI3K) and extracellular
 
signal–related kinase (ERK), which are required for focal adhe-
sion disassembly. Because CRT is not a transmembrane protein,
it is likely that CRT acts in association with a coreceptor.
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*Abbreviations used in this paper: 
 
 
 
2
 
M, 
 
 
 
2
 
-macroglobulin; BAE, bovine
aortic endothelial; CRT, calreticulin; ERK, extracellular signal–related
kinase; LRP, low density lipoprotein receptor–related protein; MEF,
mouse embryonic fibroblast; PI3K, phosphoinositide 3 kinase; PTX,
pertussis toxin; RAP, receptor-associated protein; TSP, thrombospondin.
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The low density lipoprotein receptor–related protein
(LRP), also known as CD91 or the 
 
 
 
2
 
-macroglobulin (
 
 
 
2
 
M)
receptor, is a member of a family of multi-ligand binding
proteins involved in numerous biological functions (Herz
and Strickland, 2001; Strickland et al., 2002). Among its
ligands is the NH
 
2
 
-terminal heparin-binding domain of
TSP; LRP mediates endocytic degradation of TSP (Godyna
et al., 1995; Mikhailenko et al., 1997). There is also indirect
evidence for the association of LRP with CRT. CRT com-
petitively inhibited the association of LRP with heat shock
protein gp96 (Basu et al., 2001). CRT and LRP are colocal-
ized on the macrophage cell surface by immunohistochemis-
try, where they function as coreceptors for macropinocytosis
of necrotic cells (Ogden et al., 2001). Although these data
suggest that CRT and LRP can form bimolecular signaling
complexes, there are actually no direct data to show binding
of these two proteins.
Once considered primarily for its role in endocytosis, it is
becoming clear that LRP and other family members associ-
ate with a number of cytoplasmic adaptor molecules and
participate in signaling of multiple cellular functions (Hus-
sain, 2001; Strickland et al., 2002). LRP is a 600-kD trans-
membrane protein composed of one 515-kD heavy (
 
 
 
)
subunit and one 85-kD light (
 
 
 
) subunit noncovalently
attached to each other (Herz et al., 1990; Willnow et al.,
1996). The light subunit has a transmembrane domain and
a cytoplasmic tail that contains two NPxY sequences (Glie-
mann et al., 1994). These motifs are available for interac-
tions with adaptor or scaffolding molecules, such as Shc,
FE65, and Disabled-1 (Ermekova et al., 1997; Trommsdorff
et al., 1998, 1999; Barnes et al., 2001). LRP is localized in
caveolae, and is rapidly and transiently tyrosine phosphory-
lated by the PDGF receptor in a src- and PI3K-dependent
manner (Boucher et al., 2002; Loukinova et al., 2002).
PDGF-mediated phosphorylation of LRP’s cytoplasmic do-
main results in increased association of the adaptor protein
Shc with LRP. Expression of a chimeric protein with the
LRP cytoplasmic domain increases JNK association at the
plasma membrane, inhibiting JNK translocation to the nu-
cleus and gene regulation (Lutz et al., 2002). Other LRP
family members (LRP5 and LRP6) act as coreceptors with
the G protein–coupled receptor Frizzled in the Wnt signal-
ing pathway, suggesting a role in transcriptional regulation
(Tamai et al., 2000; Wehrli et al., 2000). Finally, 
 
 
 
2
 
M bind-
ing to LRP on macrophages activates PI3K (Misra and
Pizzo, 1998).
Here, we report that LRP acts as the coreceptor for cell
surface CRT to mediate focal adhesion disassembly in re-
sponse to the hep I sequence of TSP. Our results demon-
strate that LRP is necessary for focal adhesion disassembly
by TSP because the LRP antagonist, receptor-associated
protein (RAP), or antibodies against LRP block TSP/hep
I–induced focal adhesion disassembly, and LRP-deficient
cells do not signal in response to TSP/hep I treatment. Fur-
thermore, we provide the first direct evidence that LRP and
CRT interact and that hep I, CRT, and LRP are complexed
in cells. These results establish LRP as a signaling coreceptor
for CRT and provide evidence for a novel function for LRP
in regulation of cell adhesion.
 
Results
 
Anti-LRP antibodies and RAP block TSP/hep I–mediated 
focal adhesion disassembly
 
The ability of cell surface CRT to signal focal adhesion dis-
assembly despite its lack of a transmembrane domain sug-
gests that CRT signals through associations with a corecep-
tor. Recent reports showed that LRP, a known receptor for
TSP, colocalizes with CRT on the surface of macrophages
(Ogden et al., 2001) and that CRT can competitively block
the binding of heat shock protein gp96 to LRP (CD91) on
antigen-presenting cells (Binder et al., 2000). These data
prompted us to ask whether LRP might act as a coreceptor
for CRT to mediate TSP signaling of focal adhesion disas-
sembly.
To test this hypothesis, we used a pAb (anti-CD91) raised
against a 75–80-kD fragment of the LRP heavy chain (extra-
cellular domain). This antibody blocked focal adhesion dis-
assembly by hep I (Fig. 1). Similarly, a second LRP pAb
(R2629) that recognizes multiple epitopes in the ligand-
binding regions of the heavy chain of LRP also blocked hep
I stimulation of focal adhesion disassembly (unpublished
data). These antibodies also blocked focal adhesion disas-
sembly by TSP (unpublished data). Incubation of the cells
with the antibodies alone did not affect the number of cells
positive for focal adhesions, demonstrating that blockade of
LRP in the absence of a TSP stimulus is not sufficient to al-
ter focal adhesion stability.
To further investigate the role of LRP in focal adhesion
disassembly, we also tested the ability of RAP to block TSP-
mediated focal adhesion. RAP is a chaperone for LRP (and
other low density lipoprotein receptor family members) that
blocks the binding of ligands to LRP (Strickland et al.,
1991; Kounnas et al., 1992a; Medh et al., 1995). Pretreat-
ment of cells with RAP blocked the ability of hep I and TSP
to induce focal adhesion disassembly (Fig. 2). RAP alone
Figure 1. Anti-LRP antibody inhibits hep I–induced focal adhesion 
disassembly. BAE cells grown on coverslips were incubated with 
rabbit anti-LRP antibody (anti-CD91) for 30 min, washed, and then 
incubated with 1  M hep I or DMEM (control) for 30 min. Cells 
were examined by interference reflection microscopy and assayed 
for the percentage of cells positive for focal adhesions   SD (n   3). 
A minimum of 300 cells per condition were evaluated. ***, P   0.001 
vs. DMEM.T
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had no effect on the number of cells positive for focal adhe-
sions.
The NH
 
2
 
 terminus of TSP binds LRP, although the exact
binding site in TSP has not been identified (Godyna et al.,
1995; Mikhailenko et al., 1997). Therefore, we examined
whether preincubation of either hep I or TSP with LRP was
able to block focal adhesion disassembly, potentially by
binding to the hep I sequence and inhibiting the ability of
TSP/hep I to bind CRT. LRP preincubation did not affect
the ability of hep I or TSP to stimulate focal adhesion disas-
sembly (Fig. 2). These data suggest that LRP does not bind
TSP through the hep I sequence. Furthermore, we were un-
able to demonstrate hep I–LRP interactions in binding as-
says in which hep I was immobilized in microtiter wells and
incubated with purified LRP (unpublished data).
 
LRP-deficient cells do not respond to stimulation 
by hep I
 
To further confirm whether LRP plays a role in focal adhe-
sion disassembly, mouse embryonic fibroblasts (MEFs) ge-
netically deficient in LRP were treated with TSP or hep I.
Fibroblasts (MEF-1) wild type for LRP and fibroblasts het-
erozygous (PEA 10) or homozygous null (PEA 13) for LRP
were used (Willnow and Herz, 1994). Cells were incubated
with hep I peptide and analyzed for focal adhesions by inter-
ference reflection microscopy. Hep I was unable to stimulate
focal adhesion disassembly in either the heterozygous or the
homozygous LRP-null cells, although the wild-type parental
line responds to TSP and hep I as previously observed for
bovine aortic endothelial (BAE) cells and other MEF strains
(Fig. 3). The PEA 10 cells, which are heterozygous for the
LRP gene and express 
 
 
 
50% of wild-type levels of LRP, do
not respond to hep I, suggesting that there is a critical level
of LRP expression on the cells necessary to mediate focal ad-
hesion disassembly (Fig. 3). In contrast, both PEA 10 and
PEA 13 MEFs were able to respond to the active fragment of
tenascin-C, suggesting that the failure to respond to TSP/
hep I is not due to a generalized defect in these cells (Mur-
phy-Ullrich et al., 1991; Fig. 3).
 
Binding of recombinant CRT and purified LRP
 
The preceding data are supportive of a role for LRP as the
signaling coreceptor for CRT. However, there is no direct
evidence that LRP and CRT form a molecular complex.
Therefore, we investigated binding of CRT and LRP. Bind-
ing of recombinant CRT and purified LRP was assessed by
immunoprecipitation with rabbit anti-CRT antiserum, fol-
lowed by immunoblotting with anti-LRP antibody to detect
bound LRP. A band that migrated at the same mol wt as pu-
rified LRP was detected in samples incubated with CRT
(Fig. 4). LRP was not detected in samples precipitated with
nonimmune rabbit serum. Furthermore, the binding be-
tween CRT and LRP was inhibited by the LRP ligand, RAP
(Fig. 4). The ability of RAP to block CRT interactions with
LRP is specific for LRP because RAP does not inhibit CRT
binding to TSP (unpublished data). CRT–LRP complex
formation is specific in these assays, as LRP does not bind
BSA (Fig. 4). These data provide direct evidence that CRT
and LRP can form a molecular complex. Furthermore, the
ability of RAP to block both CRT–LRP complex formation
and focal adhesion disassembly by hep I strongly suggests
that CRT–LRP complex formation is necessary for signaling
of focal adhesion disassembly.
Figure 2. RAP (but not LRP) inhibits TSP/hep I–induced focal 
adhesion disassembly. BAE cells grown on coverslips were incubated 
for 30 min with 2  M RAP or DMEM (control) before addition of 
100 nM hep I or 68 nM TSP for 30 min. In addition, LRP at 10-fold 
molar excess to 100 nM hep I or 340 nM TSP was incubated with 
10 nM hep I or 34 nM TSP for 30 min before addition to cells for 30 
min. Cells were fixed and examined for the number of cells positive 
for focal adhesions by interference reflection microscopy. Results 
are the mean   SD (n   3). *, P   0.05; **, P   0.01; ***, P   
0.001 vs. DMEM.
Figure 3. hep I does not induce focal adhesion disassembly. LRP-
deficient wild-type (CRL-2214), PEA 10 (LRP  / ), and PEA 13 (LRP 
 / ) cells grown on coverslips were incubated with 1  M hep I, 68 
nM TSP, 30  g/ml TN-C fnIIIA-D, or DMEM (untreated) for 30 min 
at 37 C. Cells were fixed and examined for focal adhesions by inter-
ference reflection microscopy in at least 250 cells/coverslip. Results 
are the mean percentage of cells positive for focal adhesions   
SD (n   3).T
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CRT and LRP are associated with each other 
in BAE cell lysates
 
To establish whether CRT and LRP form complexes in BAE
cells, detergent extracts of membranes from cells treated
with hep I were analyzed for the presence of CRT in anti-
LRP immunoprecipitates. CRT is present in anti-LRP (but
not in nonimmune IgG) immunoprecipitates, indicating
that the two proteins are associated in cells. Treatment with
hep I, but not modified hep I, enhances association of LRP
and CRT (Fig. 5 A). Similarly, LRP was detected in deter-
gent extracts of BAE membranes immunoprecipitated with
anti-CRT antiserum (Fig. 5 B). LRP was complexed with
membrane-associated CRT after hep I treatment, but not in
untreated cells or cells treated with the inactive peptide.
These data indicate that, in addition to forming bimolecular
complexes in vitro, CRT and LRP are associated in cells and
hep I treatment enhances CRT–LRP association.
Also, we examined whether hep I and LRP form com-
plexes in cells. Biotin-tagged hep I was added to wild-type or
CRT nulls, and proteins associated with the biotin-tagged
peptide were isolated by immunoprecipitation with neutra-
vidin-coupled beads. LRP was detected in lysates from wild-
type (but not from CRT-null) MEFs (Fig. 6 A). In cells
treated with nontagged hep I or another biotin-tagged
CRT-binding peptide (GQPMYGQPMY), no LRP was de-
tected in the neutravidin precipitates. On these membranes
stripped and reprobed with anti-CRT antibody, CRT mi-
grating as a high mol wt protein was detected in immuno-
precipitated material from the wild-type cells treated with
biotin–hep I (unpublished data). CRT associated with the
control CRT-binding peptide migrated at 60 kD (unpub-
lished data). LRP is specifically associated with the biotin–
hep I–CRT complex because we failed to detect association
of another membrane protein, 
 
 
 
3
 
 integrin, with this com-
plex (Fig. 6 B). The inability to precipitate LRP from CRT-
null cells is not due to a lack of LRP in these cells, as there is
equivalent staining for LRP in immunoblots of extracts of
wild-type and CRT-null MEFs (Fig. 6 C). Hep I–CRT–
LRP complex formation is not limited to fibroblasts, as these
complexes were also detected in BAE cells (unpublished
data).
 
LRP is necessary for ERK and signaling downstream of 
TSP/hep I binding to CRT
 
If LRP is acting as the signaling coreceptor for CRT, then
LRP should be necessary for downstream signals induced by
TSP/hep I binding to CRT. Hep I activates PI3K and ERK,
and the activity of these mediators is required for hep
I–stimulated focal adhesion disassembly (Greenwood et al.,
1998; Orr et al., 2002). CRT is necessary for PI3K and ERK
signaling in response to hep I (Goicoechea et al., 2000; Orr
et al., 2002). Therefore, we tested whether cells that either
lack or have reduced levels of LRP are capable of activating
these downstream effectors of TSP/hep I signaling.
Treatment of cells with 1 
 
 
 
M hep I peptide stimulated a
significant increase in ERK phosphorylation in wild-type
cells (Fig. 7, A and B). In contrast, there was no stimulation
of ERK phosphorylation in the homozygous LRP-deficient
cell line PEA 13 (Fig. 7 A). The PEA 10 line heterozygous
for LRP showed a reduced ability to phosphorylate ERK in
response to hep I treatment. Further evidence for the role of
LRP in hep I signaling is seen by the ability of RAP to block
ERK phosphorylation in response to hep I in wild-type
MEF cells (Fig. 7 B).
The function of LRP as a component of the receptor com-
plex–mediating activation of PI3K was also studied. The
generation of PtdIns-P
 
3
 
 in response to stimulation with hep
I was examined in an in vitro kinase assay. These data show a
Figure 4. Recombinant CRT interacts with purified LRP. 20 nM 
CRT and 10 nM LRP were incubated together in the presence or 
absence of 10 nM RAP, and then complexes were immunoprecip-
itated with anti-CRT antiserum or nonimmune rabbit serum. Alter-
nately, LRP was incubated with BSA, and LRP bound to BSA was 
immunoprecipitated with anti-BSA antibody. LRP bound to CRT or 
BSA was detected after electrophoresis and transfer to nitrocellulose 
membranes with anti-LRP antibody (8G1).
Figure 5. LRP and CRT form complexes 
in BAE cells. (A) BAE cells were treated 
with DMEM, 1  M hep I, or 1  M modi-
fied hep I for 10 min, and N-octylgluco-
pyranoside membrane extracts were 
immunoprecipitated with mouse anti-
LRP antibody (5A6) or nonimmune IgG 
bound to GammaBind G Sepharose 
beads. Bound complexes were resolved 
by SDS-PAGE under nonreducing 
conditions, and CRT was detected by 
immunoblotting with goat–anti-CRT IgG. 
(B) BAE cells were incubated with either 
DMEM, 1  M hep I, or 1  M modified hep I for 10 min, and detergent extracts of membranes were immunoprecipitated with anti-CRT antiserum 
or nonimmune rabbit serum; bound LRP was detected by immunoblotting with mouse anti-LRP antibody (8G1).T
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significantly reduced ability to generate PtdIns-P
 
3
 
 in PEA 10
cells that contain low levels of LRP, and a complete inability
in the LRP-deficient cell line (Fig. 8; PEA 13). In contrast,
hep I stimulated a significant increase in PtdIns-P
 
3
 
 in the
wild-type cells containing normal levels of LRP.
 
Hep I stimulates association of the G
 
 
 
i2
 
 subunit 
with LRP
 
Hep I/TSP signaling of focal adhesion disassembly through
cell surface CRT is PTX-sensitive and involves the G
 
 
 
i2
 
 sub-
unit of heterotrimeric G proteins (Orr et al., 2002). Because
ligand stimulation can induce association of G protein sub-
units with LRP, we asked whether hep I treatment similarly
induced G
 
 
 
i2
 
 association with LRP in BAE cells. Lysates of
hep I–treated cells were immunoprecipitated with antibody
to LRP, and the association of the G
 
 
 
i2
 
 subunit was assessed
by immunoblotting with an antibody specific for this sub-
unit. Data show that hep I induces a time-dependent associ-
ation of the G
 
 
 
i2
 
 subunit with LRP, consistent with the
kinetics of hep I–stimulated focal adhesion disassembly
(Greenwood et al., 1998; Fig. 9 A). TSP, but not the modi-
fied hep I peptide, also stimulates LRP–G
 
 
 
i2
 
 association
(Fig. 9 B). Further evidence that G protein association with
LRP is dependent on hep I stimulation is shown by the abil-
ity of RAP to block LRP–G protein binding in response to
hep I (Fig. 9 C). The association of G
 
 
 
i2
 
 with LRP is
blocked by a membrane-permeable peptide that inhibits
binding of the G
 
 
 
i2
 
 subunit to receptors, but not by a re-
lated peptide that specifically blocks G
 
 
 
i3
 
 binding to recep-
tors (Fig. 9 D). This peptide blocks hep I–dependent focal
adhesion disassembly and signaling (Orr et al., 2002). Hep I
induces G
 
 
 
 subunit association specifically with LRP be-
cause there was no stimulation of G
 
 
 
 association with either
the Angiotensin II type 1 receptor or the EGF receptor (Fig.
9 E). These data link LRP to the PTX-sensitive signal-
ing pathway activated by TSP/hep I binding to cell sur-
face CRT.
 
Discussion
 
These analyses identify LRP as the signaling coreceptor for
cell surface CRT in mediating TSP-induced focal adhesion
Figure 6. LRP forms molecular com-
plexes with biotin-tagged hep I peptide 
in wild-type (but not CRT-null) cell 
extracts. (A) Wild-type and CRT-null MEFs 
were incubated for 10 min with 1  M 
untagged hep I peptide, 10 nM–1  M 
biotin-tagged hep I, 1  M biotin-tagged 
modified hep I, or 1  M biotin-tagged 
CRT binding peptide. Detergent extracts 
of cells were coprecipitated with neutra-
vidin beads to precipitate proteins 
associated with biotin peptides. LRP 
coprecipitating with the biotin–hep I 
complexes was detected by immunoblot 
with rabbit anti-LRP antibody (R2629). 
LRP was detected in the neutravidin–
biotin precipitates from wild-type (but 
not from CRT-null) MEFs. LRP was not 
detected in samples treated with non-
tagged hep I, biotin modified hep I, or 
the biotin CRT–binding peptide. (B) 
Wild-type and CRT knockout MEFs were 
treated with 1  M untagged hep I, biotin-
tagged hep I, or biotin-tagged modified 
hep I, and associated proteins were pre-
cipitated with neutravidin. Precipitated 
proteins and proteins in the supernatant 
were assessed by immunoblotting for  3 
integrin and then for CRT in the same 
membrane. (C) LRP levels were assessed 
by immunoblot in equivalent amounts of 
cell protein (50  g) from wild-type and 
CRT-null MEFs.T
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disassembly. They provide evidence that LRP binds CRT
and that hep I, CRT, and LRP form molecular complexes in
cells. Hep I appears to enhance CRT–LRP complex forma-
tion. Furthermore, we show that LRP is necessary for focal
adhesion disassembly induced by hep I and for generation of
the downstream signaling mediators that are required to
stimulate reorganization of focal adhesions. There is a criti-
cal level of LRP expression that is required to mediate TSP–
CRT signaling, as cells that express LRP at significantly re-
duced levels were unable to signal in response to TSP/hep I.
LRP appears to be a specific effector of TSP-mediated focal
adhesion disassembly because tenascin-C retained its ability
to signal focal adhesion disassembly in LRP-deficient fibro-
blasts. Finally, we provide evidence linking LRP to the PTX-
sensitive G protein subunit involved in hep I signaling of fo-
cal adhesion disassembly.
It is becoming clear that beyond its role as a molecular
chaperone, CRT also regulates multiple cellular functions as
a cell surface protein (Eggleton et al., 1994; Arosa et al.,
1999; Johnson et al., 2001; Seddiki et al., 2001). In addition
to mediating focal adhesion disassembly in response to TSP,
CRT modulates melanoma cell spreading on laminin sub-
strates (White et al., 1995) and fibroblast proliferation in re-
sponse to fibrinogen (Gray et al., 1995). The mechanisms
whereby cell surface CRT mediates cellular signals have not
been previously described. Evidence that CRT signaling is
PTX-sensitive in at least three different cell types suggests
that heterotrimeric G protein signaling might be a common
mechanism (Cho et al., 1999, 2001). Signaling by an anti-
bacterial peptide in U937 monocytes to generate O
 
2
 
 
 
 
 
occurs
in a G protein–dependent manner (Cho et al., 2001). Fur-
thermore, cell surface CRT similarly mediates the effects of
this anti-microbial peptide on neutrophils through PTX-
sensitive G proteins (Cho et al., 1999). These findings are
consistent with our data showing that TSP stimulates focal
adhesion disassembly through activation of PTX-sensitive
G
 
 
 
i2
 
 proteins and ERK phosphorylation (Orr et al., 2002),
and with the current data showing that hep I stimulates as-
sociation of LRP with the G
 
 
 
i2
 
 subunit.
Typically, heterotrimeric G proteins are associated with
seven transmembrane-spanning receptors (Gilman, 1987).
Although it might be atypical for the G
 
 
 
i2
 
 subunit to associ-
ate with LRP and mediate signaling, there is precedent for
such signaling mechanisms. G proteins are known to associ-
ate with single transmembrane types of receptors such as the
receptors for insulin, erythropoietin, EGF, and IGF-I and
Figure 7. TSP/hep I requires LRP to activate ERK. (A) Wild-type 
(K41), PEA10 (LRP / ), and PEA13 (LRP / ) MEFs were grown to 
near confluence in 6-well plates in 1% FBS overnight. Cells were 
incubated in serum-free DMEM cells (4 h) and then treated for 10 
min with either 1  M DMEM or 1  M hep I. Cells lysates were 
analyzed for total and phospho-ERK by immunoblotting. Levels of 
phospho-ERK were determined through densitometry and normalized 
to total ERK levels. Results are the mean arbitrary absorbance units   
SD (n   3–4). *, P   0.05 vs. DMEM. (B) K41 MEFs were treated as 
in A, except that some cultures were treated with 50 nM RAP for the 
last hour of serum starvation. Cell lysates were probed for phos-
phoERK and total ERK as in A. Results are the mean arbitrary absor-
bance units   SD (n   3–4). *, P   0.05; **, P   0.01 vs. DMEM.
Figure 8. Hep I–mediated PI3K activation requires LRP. Wild-type 
K 41 MEFs, PEA10, and PEA13 cells were grown to near confluence, 
serum deprived overnight in 0.2% FBS, and treated with either 1 
 M DMEM or 1  M hep I for 30 min. Cells were lysed and immuno-
precipitated with anti-p85 PI3K antibodies. Immunoprecipitates then 
underwent an in vitro lipid kinase assay by successive incubations 
with phosphatidylinositol-4,5-bisphosphate (PIP2) and [
32P]ATP. 
Phosphorylated lipids were separated by TLC, detected by autora-
diography, and analyzed using densitometry. Results are the mean 
arbitrary absorbance units   SD (n   3–5). *, P   0.05; ***, P   
0.001 vs. DMEM.T
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IGF-II (Yang et al., 1991; Krieger-Brauer et al., 1997;
Fedorov et al., 1998; Hallak et al., 2000; Guillard et al.,
2001). LRP has been shown to associate with heterotrimeric
G proteins, primarily G s, in melanoma cells (Goretzki, and
Mueller, 1998). There is also evidence that LRP is involved
in G protein signaling; apoE4 binding to LRP stimulates
PTX-sensitive neuronal cell apoptosis in association with
G i subunits (Hashimoto et al., 2000). ApoE peptides or ac-
tivating antibodies to LRP stimulate an increase in cytosolic
calcium in an LRP- and PTX-sensitive manner (Wang and
Gruenstein, 1997; Misra et al., 1999). Our present work
provides further evidence for the involvement of LRP in G
protein signaling and shows that LRP–G protein interac-
tions are involved in regulation of a defined biological re-
sponse, focal adhesion disassembly.
Evidence suggests that CRT and LRP interactions are
physiologically important. CRT plays a role in C1q signal-
ing of apoptotic cell ingestion through association with
LRP, and the two proteins colocalize on the surface of mac-
rophages (Ogden et al., 2001). Furthermore, CRT and an-
other LRP family member, megalin, both bind C1q (Sim et
al., 1998). Other data show that interactions of heat shock
proteins gp96, hsp90, and hsp70 with LRP are competi-
tively blocked by CRT, and antibody to LRP blocks antigen
presentation by CRT (Basu et al., 2001). Our data are con-
sistent with these observations that CRT–LRP interactions
are important in cellular processes and demonstrate a new
role for LRP in focal adhesion disassembly.
LRP has signaling functions distinct from its role as a
cargo transport protein (Hussain, 2001; for review see
Strickland et al., 2002). LRP has two NPxY signaling motifs
in its cytoplasmic domain; however, endocytosis depends
primarily on a YXXL sequence immediately after the second
NPxY motif (NPVYxxL). Both NPxY motifs appear to in-
teract with signaling adaptor molecules (Li et al., 2000).
LRP associates with numerous adaptor molecules including
Fe65 (Ermekova et al., 1997), Disabled-1 (Dab-1; Tromms-
dorff et al., 1998, 1999), JIP 1 and 2 (Gotthardt et al.,
2000), and Shc (Barnes et al., 2001). A tyrosine-phosphory-
lated form of LRP copurified with Shc in v-src transformed
cells (Barnes et al., 2001). This finding is intriguing, as Shc
activates the Ras signaling pathway and downstream ERK
activation through recruitment of Grb2-Sos (Nakamura et
al., 2002). Recently, we showed that TSP/hep I signaling
through CRT stimulates ERK activity, and that ERK activ-
Figure 9. Hep I stimulates association of LRP with the G i2 subunit, 
and association is blocked by RAP and by peptides corresponding 
to the COOH terminus of G i2. (A) BAE cells were grown to near 
confluence and serum deprived overnight. Cells were then treated 
with 1  M hep I for 0, 5, 10, 15, or 30 min and lysed. Cell lysates 
were immunoprecipitated with monoclonal anti-LRP antibody 
(8G1), separated by SDS-PAGE, and immunoblotted with mouse 
anti-G i2 antibodies. A representative immunoblot for LRP-associated 
G i2 is shown. Bands were analyzed using One-Dscan software 
(Scanalytics), and the fold change in LRP-G i2 association as compared 
with untreated conditions was determined. Equal loading of sample 
protein was assessed by protein staining with Ponceau S. *, P   0.05; 
**, P   0.01 (n   3–5). (B) BAE cells were grown as in A, treated for 
10 min with either DMEM, 100 nM hep I, 78 nM TSP, or 100 nM 
modified hep I and assayed for LRP-G i2 association as described in A. 
A representative immunoblot for LRP-associated G i2 is shown (n   3). 
(C) BAE cells were grown as in A and pretreated for 1 h in DMEM 
with or without 50 nM RAP and then treated with either DMEM or 
1  M hep I for 10 min and assayed for LRP-G i2 association as 
described in A. **, P   0.01 (n   4). (D) BAE cells were pretreated 
for 1 h in DMEM with or without 1  M membrane-permeable 
sequence (MPS)-G i2 or MPS-G i3 peptides. Cells were then treated 
with either DMEM or 1  M hep I for 10 min and lysed. Cells were 
then treated with either DMEM or 1  M hep I for 10 min and assayed 
for LRP-G i2 association as described in A. **, P   0.01 (n   3–5). 
(E) BAE cells were treated with either DMEM or 1  M hep I for 10 
min and lysed. Cell lysates were immunoprecipitated with anti-LRP 
antibody (8G1), anti-angiotensin II type 1 receptor antibody, or 
anti-EGF receptor antibody, separated by SDS-PAGE, and immuno-
blotted with mouse anti-G i2 antibodies. Results are representative 
of at least three experiments.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
1186 The Journal of Cell Biology | Volume 161, Number 6, 2003
ity is required for focal adhesion disassembly (Orr et al.,
2002). LRP also appears to be involved in PI3K signaling as
 2M binding to LRP on peritoneal macrophages activates
PI3K (Misra and Pizzo, 1998). This is consistent with our
observations that cells deficient in LRP do not activate PI3K
in response to hep I stimulation. Together, these observa-
tions support a direct role for LRP in transmitting signals
from TSP bound to CRT.
Also, we report here that LRP binds CRT and forms
complexes with CRT in cells. TSP/hep I binds aa 19–36 of
the N-domain of CRT, and this interaction mediates focal
adhesion disassembly (Goicoechea et al., 2002). Our in
vitro binding analyses suggest that hep I binding to CRT
does not interfere with the ability of LRP to bind CRT
(unpublished data). On the contrary, hep I increases
CRT–LRP association at the cell membrane. PAI-1 bind-
ing to uPAR exposes a cryptic binding site on uPAR for
LRP (Stefansson et al., 1998). TSP/hep I binding to CRT
might also alter CRT structure, exposing a new or addi-
tional LRP binding sites. Hep I potentially induces CRT
clustering at the membrane, thereby increasing CRT affin-
ity for LRP. This model is consistent with the fact that
CRT binding to cells in the absence of hep I is insufficient
to signal focal adhesion disassembly (Goicoechea et al.,
2000, 2002), and the present observation that LRP co-
complexes with a higher mol wt form of CRT.
The extracellular binding domains of LRP involved in
binding CRT are not known. Interestingly, the ligand-bind-
ing clusters of LRP are comprised of cysteine-rich comple-
ment-like repeats (Herz and Strickland, 2001). C1q is a
known ligand of CRT, and CRT has been referred to as the
cC1q receptor (Eggleton et al., 1998). C1q binds to a site
spanning the N and P domains (aa 160–283) of CRT (Stuart
et al., 1997; Kovacs et al., 1998). It is interesting to speculate
that CRT recognizes these complement-like domains of LRP.
Although the NH2-terminal heparin-binding domain of
TSP binds LRP, and LRP mediates the endocytic degrada-
tion of TSP1 and 2 (Godyna et al., 1995; Mikhailenko et
al., 1997), our analyses failed to demonstrate binding be-
tween LRP and the hep I sequence from the NH2-terminal
heparin-binding domain of TSP. It remains to be seen as to
whether hep I signaling through LRP modulates endocytic
degradation of TSP, or whether LRP down-regulates TSP–
CRT signaling of focal adhesion disassembly through en-
docytosis of this complex.
In summary, these works identify a novel mechanism of
CRT signaling from the cell surface through TSP-stimulated
association with LRP. Furthermore, these data link LRP to
the G i signaling pathway activated by TSP/hep I and its
downstream effectors, PI3K and ERK. Finally, these data
implicate LRP in a novel biologic response, modulation of
the intermediate cell adhesion.
Materials and methods
Cells
BAE cells were cultured in DMEM with 4.5 g/l glucose, 2 mM glutamine,
and 10% FBS (Murphy-Ullrich et al., 1993). MEF-1 (ATCC-CRL-2214), PEA
10 (ATCC-CRL-2215), and PEA 13 (ATCC-CRL-2216) cells were purchased
from the American Type Culture Collection and were grown in DMEM
with 4.5 g/l glucose, 1 mM sodium pyruvate, 1.5 g/l sodium bicarbonate,
and 10% FBS (HyClone). Wild-type (K41) and crt /  null (K42) MEFs
were a gift from Dr. M. Michalak (University of Alberta, Alberta, Canada).
Growth conditions were the same as described for BAE cells.
Antibodies
Rabbit anti-CRT antiserum was purchased from Affinity BioReagents, Inc.
Goat anti-CRT IgG (calregulin, sc-6468) was purchased from Santa Cruz
Biotechnology, Inc. Anti-CD91 rabbit pAb against LRP (used at 1:500-
1000) was a gift from Dr. R. Binder (University of Connecticut School of
Medicine, Farmington, CT; Binder et al., 2000). R2629 rabbit pAb against
LRP, developed in the Strickland lab, and mouse anti-LRP 8G1 and 5A6
antibodies (purchased from Maine Biotechnology) have been described
previously (Strickland et al., 1990; Kounnas et al., 1992b). Rabbit anti-
phospho-ERK, rabbit anti-ERK and mouse anti-EGF receptor antibodies
were purchased from Cell Signaling Technology. Rabbit anti- 3 integrin
was purchased from CHEMICON International. Mouse antibody to PI3K
(p85 subunit) and mouse anti-Gi  antibody were purchased from Upstate
Biotechnology. Mouse anti-G i2 antibody was purchased from BIOMOL
Research Laboratories, Inc. Mouse antibody to the Ang II type 1 receptor
was purchased from Abcam, Ltd.
Proteins
TSP was purified from human platelets purchased from the American Red
Cross as described previously (Murphy-Ullrich and Höök, 1989). LRP was
isolated from human placenta as described previously (Ashcom et al.,
1990). Recombinant human RAP expressed as a GST fusion protein was
purified as described previously (Williams et al., 1992). Recombinant tena-
scin-C fnIIIA-D was a gift from Dr. Harold Erickson (Duke University,
Durham, NC; Aukhil et al., 1993). cDNA for GST-CRT was a gift from Dr.
M. Michalak. Fusion proteins were expressed in Escherichia coli and puri-
fied as described previously (Baksh and Michalak, 1991; Goicoechea et
al., 2000). Hep I peptide, biotin-tagged CRT binding peptide (GQP-
MYGQPMY), and the membrane-permeable G protein inhibitory peptides
were synthesized, purified, and analyzed by AnaSpec (Murphy-Ullrich et
al., 1993; Jorgensen et al., 2000; Orr et al., 2002). Hep I peptide with an
NH2-terminal biotin tag was synthesized at the University at Alabama, Bir-
mingham Peptide Synthesis Core.
LRP-CRT binding assays
GST-CRT was expressed as described previously (Goicoechea et al.,
2000). The GST tag was cleaved using the Restriction Protease Xa cleavage
and removal kit (Roche). 20 nM recombinant CRT was incubated with 10
nM LRP with or without 10 nM RAP for 1 h at 4 C in DTO buffer (DMEM,
0.5% Tween 20, and 0.1% ovalbumin). Complexes were immunoprecipi-
tated (1 h at 4 C) with anti-CRT anti-serum (1:30) or 15  g/ml nonimmune
rabbit IgG conjugated to GammaBind G Sepharose (Amersham Bio-
sciences). As a control for nonspecific binding, LRP was incubated with 20
nM BSA in the presence or absence of RAP, and then subjected to immu-
noprecipitation with rabbit anti-BSA serum (1:30; Sigma-Aldrich) conju-
gated to GammaBind G Sepharose. Complexes were washed 7  in DTO
buffer and resuspended in Laemmli buffer. Samples were separated by
SDS-PAGE (6%), transferred to nitrocellulose, and then probed with anti-
LRP antibody (8G1) at 1  g/ml and goat anti–mouse IgG-HRP (1:10,000).
Blots were developed using Western Lightning Chemluminescence Re-
agent Plus (PerkinElmer). Band intensity was quantified by densitometry
(One-DScan software v1.31; Scanalytics).
Coprecipitation of LRP and CRT from cell extracts
BAE cells (4   100 mM) were grown to near confluence, washed three
times in DMEM, and cells were then treated with 1  M hep I or the modi-
fied hep I peptide for 10 min before harvesting by scraping. Cells were pel-
leted, and pellets were washed twice with DMEM plus protease inhibitors.
Cells were disrupted by homogenization with a tissue grinder (20 strokes)
on ice, and insoluble proteins were pelleted before detergent extraction.
The pellet was resuspended in 0.5 ml 100 mM N-octylglucopyranoside on
ice for 40–60 min. Insoluble proteins were removed by centrifugation, and
equal amounts of protein from the detergent-soluble supernatant (extract)
were used for the coimmunoprecipitation assays.
GammaBind G Sepharose beads were blocked overnight in blocking
buffer (0.1% ovalbumin in DMEM), and were then incubated for 1–2 h
with 15  l rabbit anti-CRT antiserum or nonimmune rabbit serum. Beads
were washed four times and were then incubated for 1 h at 4 C with 360
 g of BAE cell extract in an equal volume of 2  binding buffer (0.1% Tri-
ton X-100 in DMEM). Beads were washed four times with binding buffer
and immune complexes were extracted in 30  l 2  nonreducing Laemmli
buffer. LRP was detected in anti-CRT immunoprecipitated complexes byT
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immunoblotting with mouse anti-LRP antibody (8G1) at 1  g/ml. Alter-
nately, CRT was detected in samples immunoprecipitated with 5  g
mouse anti-LRP (5A6) antibody or nonimmune mouse serum by immuno-
blotting with goat anti-CRT IgG (1:1,000).
Association of LRP with biotin-tagged hep I peptide bound 
to cells
Wild-type and CRT-null MEFs were incubated with biotin-tagged hep I
peptide, untagged peptide for 10 min, washed in DMEM, and cells were
then harvested by scraping. Membrane proteins were solubilized with 50
mM N-octylglucopyranoside. Equal amounts of protein (1 mg) from each
cell type were analyzed. Proteins associated with biotinylated hep I were
coprecipitated by incubation overnight at 4 C with a 100- l slurry of neu-
travidin beads (Pierce Chemical Co.). Samples were washed seven times in
DTO buffer. Bound proteins were solubilized in Laemmli buffer and
separated by SDS-PAGE on 6% gels. After transfer to nitrocellulose, LRP
coprecipitating with the biotin peptide complexes was detected by immu-
noblotting with 1  g/ml rabbit anti-LRP antibody (R2629). In replicate ex-
periments, membranes were probed with rabbit antibody to  3 integrin
and then stripped and reprobed with chicken anti-CRT. Equal amounts (50
 g) of detergent extract from the wild-type and CRT-null MEFS were
probed for LRP by immunoblotting with rabbit anti-LRP antibody (R2629).
In some experiments, replicate blots were probed with anti-CRT antiserum
to confirm peptide binding. A biotin-tagged peptide known to bind CRT
(GQPMYGQPMY; Jorgensen et al., 2000), but which does not stimulate fo-
cal adhesion disassembly was also tested.
Focal adhesion assay
The focal adhesion assays were performed as described previously (Mur-
phy-Ullrich and Höök, 1989). Cells were preincubated under serum-free
conditions for 30 min before treatment for 30 min at 37 C with hep I or TSP.
Endogenous TSP production during the course of these assays is not a factor
because mouse fibroblasts derived from TSP1 and TSP2 double knockout
animals respond to TSP1 and hep I as do wild-type cells (fibroblasts were a
gift of Dr. Paul Bornstein, University of Washington, Seattle, WA.
ERK activation assay
ERK activity was determined by Western blotting using phosphorylation
state–specific antibodies of whole-cell lysates as described previously (Orr
et al., 2002).
Immunoprecipitation and PI3K assay
Phosphatidylinositol (4,5)-bisphosphate (PIP2) was obtained from Ameri-
can Radiolabeled Chemicals, and [
32P]ATP was purchased from Amer-
sham Biosciences. PI3K activity was assessed in an in vitro kinase assay in
anti-p85 immunoprecipitates using a PIP2 substrate as described previously
(Greenwood et al., 1998).
G protein pull-down assay
BAE cells were grown to near confluence, serum-deprived, and incubated
with either DMEM or hep I, modified hep I, or TSP. Cells were lysed and
immunoprecipitated with mouse anti-LRP (8G1) antibody for 2 h at 4 C as
described previously (Orr et al., 2002). In some experiments, lysates were
immunoprecipitated with antibodies to either the angiotensin II type 1 re-
ceptor or to the EGF receptor. As an additional control, cells were preincu-
bated for 1 h with 50 nM RAP before addition of hep I. Immunoprecipi-
tates were analyzed for G i2 association by immunoblotting with mouse
anti-G i2 antibodies followed by HRP-conjugated goat anti–mouse IgG
(1:5,000). Bands were visualized with chemiluminescence reagent (NEN
Life Science Products).
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